Norovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)
Conditions:   Norovirus Infections;   Norwalk Gastroenteritis Interventions:   Biological: low-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine;   Biological: high-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine;   Biological: placebo Sponsors:   National Vaccine and Serum Institute, China;   Lanzhou Institute of Biological Products Co., Ltd;   Beijing Zhong Sheng Heng Yi Pharmaceutical Technology Co., Ltd.;   Zhengzhou University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2021 Category: Research Source Type: clinical trials

Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)
Conditions:   Norovirus Infections;   Norwalk Gastroenteritis Interventions:   Biological: low-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine;   Biological: high-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine;   Biological: placebo Sponsors:   National Vaccine and Serum Institute, China;   Lanzhou Institute of Biological Products Co., Ltd;   Beijing Zhong Sheng Heng Yi Pharmaceutical Technology Co., Ltd.;   Zhengzhou University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2021 Category: Research Source Type: clinical trials

Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines
Condition:   Norovirus Infections Intervention:   Biological: VXA-G1.1-NN Sponsor:   Vaxart Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2021 Category: Research Source Type: clinical trials